Is it too soon for a Nobel Prize for the Covid vaccine?

mRNA pioneers, Oxford vaccine scientists and Bill Gates are potential contenders for science’s top prize

Published on
February 10, 2021
Last updated
February 19, 2021
Jack Grove
Melinda Gates and Bill Gates on stage during the Robin Hood Foundation’s 2018 benefit in New York City.
Source: Getty
Melinda and Bill Gates in 2018
Read more about
Read more about: 
Covid-19
Research
Science, technology, engineering and mathematics (STEM)

POSTSCRIPT:

Print headline: Too soon for a Covid Nobel Prize?: mRNA pioneers, Oxford vaccine scientists and Bill Gates are potential contenders, but success of jab yet to be proved

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please
or
to read this article.

Related articles

Tug of war Marta Farra, the 'Hercules girl' at a tug of war with gold cup

Are academic prizes letting down the team?

‘Every young student of science has had a fantasy about winning a Nobel prize,’ says one laureate – and ever more rival prizes are being established. But with a cast of thousands currently pursuing the holy grail of a vaccine for Covid-19, might awards committees finally jettison their problematic focus on lone genius, asks Jack Grove

By Jack Grove
6 August

Related universities

You might also like

Sponsored

Featured jobs

See all jobs